Using a continuous glucose monitor (CGM) with education to improve satisfaction and quality of life for adults with diabetes
Official title: Continuous Glucose Monitor (CGM) Discharge Program
Run by Cedars-Sinai Medical Center · NCT06965803 · Data updated 2026-11-12
This program will try whether providing inpatient diabetes education together with a continuous glucose monitor (CGM) improves satisfaction and quality of life for adults with Type 1 or Type 2 diabetes who use insulin.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 37 (estimated) |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT06965803 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with Type 1 or Type 2 diabetes who use insulin, speak English, own a smartphone, are scheduled for standard inpatient diabetes education, have not used a CGM in the past six months, and can provide informed consent.
✕Probably not a fit
Pregnant patients, non-English speakers, those who have used a CGM within six months, people not on insulin, or patients without a smartphone are unlikely to be eligible or to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center observational program at Cedars-Sinai where adults with Type 1 or Type 2 diabetes on insulin who have not used a CGM in the prior six months receive standard inpatient diabetes education and a CGM. Participants complete a satisfaction and quality-of-life survey before and after the intervention to measure changes in patient-reported outcomes. The intervention requires smartphone ownership and English fluency and is limited to patients able to provide informed consent. No randomization or experimental drug/device procedures beyond usual CGM use are described.
Why it matters
Potential benefit: If successful, combining education with CGM use could increase user satisfaction and improve daily quality of life for people on insulin.
How similar studies have gone: Previous research has shown that CGM use combined with diabetes education often improves patient satisfaction and glycemic outcomes, so this program builds on established findings in a focused inpatient setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 18 or older * diagnosed with Type 1 or Type 2 Diabetes who are on insulin * able to speak and understand English language * scheduled to receive a standard inpatient diabetes education consultation * must not have used CGM in the six months prior to admission * owns a smartphone * demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program Exclusion Criteria: * those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices. * non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.
Where it's running
-
Cedars-Sina Medical Center
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: Mathew P Monterola, Doctor of Nursing Practice
- Email: Mathew.Monterola@cshs.org
- Phone: 3109677434
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.